Inhibitor Therapeutics announces annual shareholder meeting
INTI•Adjournment proposal included
An additional proposal seeks authorization to adjourn the meeting if needed to secure sufficient votes on the other items.
Directors, auditor, and equity plan on the ballot
Items include the election of six directors, covering Francis E. O'Donnell, Samuel J. Sears, Niraj Vasisht, plus three others.
Shareholders will also vote on ratifying Cherry Bekaert as independent auditor for fiscal 2026.
The ballot also covers approval of the 2025 equity incentive plan, an advisory say-on-pay vote, plus the frequency of future say-on-pay votes.
Annual shareholder meeting scheduled for Sept. 15, 2026
Inhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, to be held via the internet.
